2020
DOI: 10.4236/jdm.2020.102008
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of Premature Ejaculation among Patients with Type 2 Diabetes in a Tertiary Health Institution: A Cross-Sectional Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(8 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…72,82 Supporting this, are reports from a recently published cross-sectional study finding a greater than fourfold prevalence of PE in those who had DM-related ED than those without ED. 83 Given that the majority of ED in DM is attributed to DM-related neuropathy and endothelial dysfunction, it supports the aetiological role of neuropathy in DM-related EjD. Hence, in diabetic patients who report ED (the more frequently reported sexual dysfunction in DM), EjD should also be actively enquired about.…”
Section: Concomitant Edmentioning
confidence: 85%
See 3 more Smart Citations
“…72,82 Supporting this, are reports from a recently published cross-sectional study finding a greater than fourfold prevalence of PE in those who had DM-related ED than those without ED. 83 Given that the majority of ED in DM is attributed to DM-related neuropathy and endothelial dysfunction, it supports the aetiological role of neuropathy in DM-related EjD. Hence, in diabetic patients who report ED (the more frequently reported sexual dysfunction in DM), EjD should also be actively enquired about.…”
Section: Concomitant Edmentioning
confidence: 85%
“…82 However, another cross-sectional study found no correlation although this study involved a much smaller sample size. 83…”
Section: Agementioning
confidence: 99%
See 2 more Smart Citations
“…Hence, it is important to diagnose any associated comorbidity such as ED, depression, prostatitis, or hyperthyroidism as they should be treated first or at the same time as PE[ 120 ]. Therefore, the treatment may involve numerous interventions as per the kind of mechanism that would cause such condition: (1) The initial management for PE is controlling the patient’s blood glucose that in some cases may allow recover the normal ejaculatory function[ 91 , 93 ]; (2) Amelioration of glycemic variability would improve PE in type 1 diabetes patients[ 96 ]; (3) In cases of concomitant ED and PE, ED should receive phosphodiesterase type 5 inhibitors before, or at least at the same time as, PE[ 91 , 93 , 94 ]. The efficacy of the combined use of phosphodiesterase type 5 inhibitors and dapoxetine in males with comorbid PE and ED are supported by some studies[ 121 - 123 ]; (4) DM-related PE patients had a worse response to 30-60 mg oral dapoxetine treatment compared to non-diabetic PE patients.…”
Section: Diabetes-related Ejaculatory Dysfunctionsmentioning
confidence: 99%